[ad_1]
On Thursday, A.Armonaitė asked A.Veryga a question about COVID-19 vaccines during Government hour.
It asked if the Minister knew that Thermo Fisher Scientific, which operates in Lithuania, was trying to invent vaccines for the US market, and asked if Lithuania was negotiating its acquisition.
Sigismund Gedvila / 15min photo / Dawn Armonaitė
“Are you negotiating with them to buy a vaccine that is manufactured here in Lithuania so that we can get it faster? I think it is very important that we do not repeat the mistakes that have been made on the reagents, on the tests [pirkimo]“, – A.Armonaitė spoke during the Seimas session.
It seems to me that it is very important that we do not repeat the mistakes that have been made on the reagents, on the tests [pirkimo].
R.Veryga replied that Lithuania does not have the right to buy vaccines from Thermo Fisher Scientific, if they are produced correctly.
Photo by Julius Kalinskas / 15min / Aurelijus Veryga
“The Member States of the European Union that have adhered to the joint purchasing mechanism cannot negotiate individually with the producers. This is a condition imposed on the Member States.
Perhaps there is a plant in Lithuania, other plants in Germany and France, and all the countries where such a producer would appear would be interested in negotiating. And these processes have started, they have been stopped by the Commission, they have put in place a common mechanism so that there are no gaps and all Member States have equal access to vaccines for their populations ”, said the Manager of Emergency Operations.
Member States of the European Union that have joined the joint purchasing mechanism cannot negotiate individually with producers. This is a condition imposed on the Member States.
A.Veryga emphasized that Lithuania does not negotiate with Thermo Fisher Scientific regarding the vaccines produced and that if we began to do so, “we would get out of the common procurement mechanism of the European Union.”
[ad_2]
